Hims & Hers

Hims & Hers is a publicly traded healthcare company, listed on the New York Stock Exchange under the ticker HIMS. Founded in 2017, the company operates a direct-to-consumer telehealth platform that connects consumers with licensed healthcare providers for personalized care. The platform spans services including treatment for hair loss, sexual health, weight management, mental health, and primary care, alongside prescription and over-the-counter medications and lab testing.

The company's technology stack is centered on telehealth and direct-to-consumer healthcare delivery. It serves millions of consumers across the United States and is recognized as one of the fastest-growing direct-to-consumer brands in the country. The company has raised over $200 million in funding to support its growth.

Hims & Hers focuses on making healthcare more accessible and convenient, with a stated mission to help people feel better through improved health outcomes. The platform is designed to normalize conversations around sensitive health topics and reduce associated stigmas.